These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1688685)

  • 1. Drusen as risk factors in age-related macular disease.
    Pauleikhoff D; Barondes MJ; Minassian D; Chisholm IH; Bird AC
    Am J Ophthalmol; 1990 Jan; 109(1):38-43. PubMed ID: 1688685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group.
    Bressler SB; Maguire MG; Bressler NM; Fine SL
    Arch Ophthalmol; 1990 Oct; 108(10):1442-7. PubMed ID: 1699513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drusen and their significance in age related macular degeneration].
    Pauleikhoff D; Barondes M; Minassian D; Chrisholm J; Wessing A; Bird AC
    Fortschr Ophthalmol; 1990; 87(5):429-32. PubMed ID: 2272567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser treatment in eyes with large drusen. Short-term effects seen in a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group.
    Ophthalmology; 1998 Jan; 105(1):11-23. PubMed ID: 9442774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic laser treatment to fellow eyes of unilateral retinal pigment epithelial tears.
    Gross-Jendroska M; Owens SL; Flaxel CJ; Guymer RH; Bird AC
    Am J Ophthalmol; 1998 Jul; 126(1):77-81. PubMed ID: 9683152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic treatment of age-related macular degeneration report number 1: 810-nanometer laser to eyes with drusen. Unilaterally eligible patients.
    Friberg TR; Musch DC; Lim JI; Morse L; Freeman W; Sinclair S;
    Ophthalmology; 2006 Apr; 113(4):622.e1. PubMed ID: 16581422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term drusen study.
    Sarraf D; Gin T; Yu F; Brannon A; Owens SL; Bird AC
    Retina; 1999; 19(6):513-9. PubMed ID: 10606451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular lesions predisposing to senile disciform macular degeneration.
    Yuzawa M; Hagita K; Egawa T; Minato H; Matsui M
    Jpn J Ophthalmol; 1991; 35(1):87-95. PubMed ID: 1716707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of subfoveal pigment epithelial detachments associated with subfoveal or unidentifiable choroidal neovascularization complicating age-related macular degeneration.
    Singerman LJ; Stockfish JH
    Graefes Arch Clin Exp Ophthalmol; 1989; 227(6):501-7. PubMed ID: 2483142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT.
    Prenner JL; Rosenblatt BJ; Tolentino MJ; Ying GS; Javornik NB; Maguire MG; Ho AC;
    Retina; 2003 Jun; 23(3):307-14. PubMed ID: 12824829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of drusen reduction after subthreshold infrared (810 nm) diode laser macular grid photocoagulation for nonexudative age-related macular degeneration.
    Rodanant N; Friberg TR; Cheng L; Aurora A; Bartsch D; Toyoguchi M; Corbin PS; El-Bradey MH; Freeman WR
    Am J Ophthalmol; 2002 Oct; 134(4):577-85. PubMed ID: 12383815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drusen in Bruch's membrane. Their significance for the pathogenesis and therapy of age-associated macular degeneration].
    Pauleikhoff D
    Ophthalmologe; 1992 Oct; 89(5):363-86. PubMed ID: 1304217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group
    Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors.
    Holz FG; Wolfensberger TJ; Piguet B; Gross-Jendroska M; Wells JA; Minassian DC; Chisholm IH; Bird AC
    Ophthalmology; 1994 Sep; 101(9):1522-8. PubMed ID: 8090455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral zinc and the second eye in age-related macular degeneration.
    Stur M; Tittl M; Reitner A; Meisinger V
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1225-35. PubMed ID: 8641826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss.
    Schatz H; McDonald HR
    Ophthalmology; 1989 Oct; 96(10):1541-51. PubMed ID: 2587050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of retinal pigment epithelial detachments associated with drusen.
    Hartnett ME; Weiter JJ; Garsd A; Jalkh AE
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(1):11-9. PubMed ID: 1547961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drusen and drusenoid macular lesions.
    Morse PH; Torczynski E; Kumar M
    Ann Ophthalmol; 1988 Sep; 20(9):327-31, 334. PubMed ID: 2461137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.